Robin Lemmens

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis.

BACKGROUND Anti-inflammatory therapies reduce the risk of major adverse cardiovascular events (MACEs) in coronary disease, but efficacy has not been shown after stroke. It is uncertain if patients with atherosclerosis are more likely to benefit from anti-inflammatory prevention. METHODS We performed a post hoc analys...